(Q34602915)

3 August 2017

1 reference

title

IGF-1 in gynaecology and obstetrics: update 2002. (English)

1 reference

3 August 2017

0 references

Druckmann R

1

1 reference

PubMed ID

11955796

3 August 2017

Rohr UD

series ordinal

2

1 reference

3 August 2017

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

41 Suppl 1

1 reference

3 August 2017

S65-83

1 reference

Growth hormone and puberty

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factors and their binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Routine addition of human insulin-like growth factor-I ligand could benefit clinical in-vitro fertilization culture

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Growth hormone: roles in female reproduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The somatotrophic axis and the reproductive process in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Growth hormone receptors in ovary and liver during gametogenesis in female rainbow trout (Oncorhynchus mykiss).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The Effect of Recombinant Bovine Somatotropin on Ovarian Function in Heifers: Follicular Populations and Peripheral Hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The effects of equine somatotropin (eST) on follicular development and circulating plasma hormone profiles in cyclic mares treated during different stages of the estrous cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Localization of binding sites for IGF-I, insulin and GH in the sow ovary.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Morphological assessment of the effect of growth hormone on preantral follicles from 11-day-old mice in an in vitro culture system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Effects of an Igf1 gene null mutation on mouse reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Recombinant human growth hormone acts on intermediate-sized follicles and rescues growing follicles from atresia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Effect of growth hormone on steroidogenesis, insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Impaired reproductive function in women treated for growth hormone deficiency during childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Transferrin and somatomedin C receptors in the human ovarian follicles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Growth hormone facilitates ovulation induction by gonadotrophins.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor I (IGF-I) levels in follicular fluid from human preovulatory follicles: correlation with serum IGF-I levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Genetic control of uterine receptivity during implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The etiology of polycystic ovary syndrome (PCO).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Serum levels of GH, IGF-I, LH and ovarian steroids in cyclic and RU486-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Influence of dehydroepiandrosterone on the expression of insulin-like growth factor-1 during cystogenesis in polycystic rat ovaries and in cultured rat granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Altered expression of insulin and insulin-like growth factor-I receptors in follicular and stromal compartments of polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Granulosa cells of polycystic ovaries: are they normal or abnormal?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The response of the growth hormone and insulin-like growth factor I axis to medical castration in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Lack of insulin-like growth factor binding protein-3 variation after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Effects of insulin on steroidogenesis in cultured porcine ovarian theca

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Identification and Content of Insulin-like Growth Factors in Porcine Oviductal Fluid1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Bovine oviductal and embryonic insulin-like growth factor binding proteins: possible regulators of "embryotrophic" insulin-like growth factor circuits

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Immunohistochemical localization of insulin-like growth factor (IGF-I), IGF-I receptor, and IGF binding proteins 1-4 in human fallopian tube at various reproductive stages

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Immunocytochemical localization of growth factors and their receptors in human pre-embryos and Fallopian tubes.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factors and their receptors in human fallopian tube in reproductive-age women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Cycle modulation of insulin-like growth factor-binding protein 1 in human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The molecular basis of embryo implantation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Immunohistochemical localization of insulin-like growth factors I and II at the primary implantation site in the Rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Placental protein 12 (PP12): a new test for the prediction of the small-for-gestational-age infant

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

The secretion of insulin-like growth factor I, prolactin and insulin-like growth factor binding protein 1 by the decidua as predictors of human fetal growth

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Role of the insulin-like growth factor family in cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Does the GH-IGF axis play a role in cancer pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Estradiol Down-Regulates the Mannose-6-Phosphate/Insulin-Like Growth Factor-II Receptor Gene and Induces Cathepsin-D in Breast Cancer Cells: A Receptor Saturation Mechanism to Increase the Secretion of Lysosomal Proenzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-Like Growth Factor Binding Protein Secretion by Breast Carcinoma Cell Lines: Correlation with Estrogen Receptor Status*

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin Regulation of Insulin-Like Growth Factor-Binding Protein Production in Cultured HepG2 Cells*

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Effect of caloric restriction on age-associated cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Breast cancer: further metabolic-endocrine risk markers?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Serum insulin-like growth factor-I and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: a possible bimodal effect depending on basal IGF-I values.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor I promotes leiomyoma cell growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Differential expression of IGF-I and IGF-II in eutopic and ectopic endometria of women with endometriosis and in women without endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Characterization of the steroid-dependence of insulin-like growth factor-binding protein-2 synthesis and mRNA expression in cultured human endometrial stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Three Distinct Forms of Insulin-Like Growth Factor Binding Proteins are Released by Decidual Cells in Culture*

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factor-I expression in normal and diseased endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Circulating Insulin-Like Growth Factor System Changes in Women with Acute Estrogen Deficiency Induced by GnRH Agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and non-osteoporotic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Androgens in postmenopausal women: production, possible role, and replacement options

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by boosting IGF-I activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Anabolic effects of rhIGF-I/IGFBP-3 in vivo are influenced by thyroid status

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Emerging anabolic treatments for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Diabetes mellitus a risk for osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900016-6

7 January 2021

10.1016/S0378-5122(02)00016-6

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11955796